The rebrand comes on the heels of the company acquiring Cook Biotech and Collagen Solutions. Evergen is the industry’s only CDMO to offer a comprehensive portfolio of allograft and xenograft biologics, according to a Dec. 17 news release.
Evergen’s regenerative medicine portfolio includes products for orthopedics, neurosurgery and sports medicine.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
